Angiogenesis in breast cancer: How should we measure this? (Review)

M. J.K. Pollitt; A. M. Hanby; K. Horgan; C. E. Murphy; P. F. Jones; V. Speirs

Angiogenesis in breast cancer: How should we measure this? (Review)

M. J.K. Pollitt, A. M. Hanby, K. Horgan, C. E. Murphy, P. F. Jones, V. Speirs^*

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

6 Citations (Scopus)

Abstract

Despite the established importance of angiogenesis in the pathogenesis of solid tumours, there is still no consensus on how this is best measured or which method is the most appropriate in the determination of prognosis. Here we review the pros and cons of current methods of assessing angiogenesis, both clinical and in the laboratory, and discuss with respect to breast cancer.

Original language	English
Pages (from-to)	931-936
Number of pages	6
Journal	Oncology Reports
Volume	13
Issue number	5
Publication status	Published - May 2005

Keywords

Angiogenesis
Breast cancer
VEGF

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{ac6c7893ccd048ebb805e80ae8094ab5,

title = "Angiogenesis in breast cancer: How should we measure this? (Review)",

abstract = "Despite the established importance of angiogenesis in the pathogenesis of solid tumours, there is still no consensus on how this is best measured or which method is the most appropriate in the determination of prognosis. Here we review the pros and cons of current methods of assessing angiogenesis, both clinical and in the laboratory, and discuss with respect to breast cancer.",

keywords = "Angiogenesis, Breast cancer, VEGF",

author = "Pollitt, {M. J.K.} and Hanby, {A. M.} and K. Horgan and Murphy, {C. E.} and Jones, {P. F.} and V. Speirs",

year = "2005",

month = may,

language = "English",

volume = "13",

pages = "931--936",

journal = "Oncology Reports",

issn = "1021-335X",

publisher = "Spandidos Publications",

number = "5",

}

TY - JOUR

T1 - Angiogenesis in breast cancer

T2 - How should we measure this? (Review)

AU - Pollitt, M. J.K.

AU - Hanby, A. M.

AU - Horgan, K.

AU - Murphy, C. E.

AU - Jones, P. F.

AU - Speirs, V.

PY - 2005/5

Y1 - 2005/5

N2 - Despite the established importance of angiogenesis in the pathogenesis of solid tumours, there is still no consensus on how this is best measured or which method is the most appropriate in the determination of prognosis. Here we review the pros and cons of current methods of assessing angiogenesis, both clinical and in the laboratory, and discuss with respect to breast cancer.

AB - Despite the established importance of angiogenesis in the pathogenesis of solid tumours, there is still no consensus on how this is best measured or which method is the most appropriate in the determination of prognosis. Here we review the pros and cons of current methods of assessing angiogenesis, both clinical and in the laboratory, and discuss with respect to breast cancer.

KW - Angiogenesis

KW - Breast cancer

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=25144522798&partnerID=8YFLogxK

M3 - Review article

C2 - 15809760

AN - SCOPUS:25144522798

VL - 13

SP - 931

EP - 936

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 5

ER -

Angiogenesis in breast cancer: How should we measure this? (Review)

Abstract

Keywords

UN SDGs

Other files and links

Fingerprint

Cite this